Literature DB >> 6945902

Childhood acute leukemia: a search for occult extramedullary disease prior to discontinuation of chemotherapy.

D H Mahoney, E T Gonzales, G D Ferry, S A Sanjad, G K von Noorden, D J Fernbach.   

Abstract

Between January 1978 and September 1979, 29 children with acute leukemia in complete continuous remission for three or more years were examined for evidence of occult extramedullary disease immediately prior to discontinuation of chemotherapy. Bilateral open wedge testicular biopsy demonstrated the presence of bilateral leukemic infiltrates in 2/13 boys. Gallium scans prior to biopsy had identified unilateral infiltration in an enlarged testis in one patient but failed to identify microscopic disease in the opposite testis or in the testes of the second patient. Percutaneous kidney and liver biopsies, pelvic ultrasonography, intravenous pyelogram, skeletal survey, cranial computed axial tomography scan, electroencephalography, and ophthalmologic examinations failed to demonstrate evidence of occult disease. Except for testicular biopsy, this study does not support extensive clinical or invasive procedures to identify extramedullary disease prior to discontinuation of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6945902     DOI: 10.1002/1097-0142(19811101)48:9<1964::aid-cncr2820480909>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Unusual Case of ALL with Ovarian Relapse.

Authors:  P K Sasidharan; M Sugeeth; P Abdul Majeed; Mohamed Shaan; B Hitha
Journal:  Indian J Hematol Blood Transfus       Date:  2014-10-17       Impact factor: 0.900

2.  Uterine and ovarian leukaemic relapse during bone marrow remission in acute lymphoblastic leukaemia.

Authors:  B Cantwell; D Cantwell; J J Fennelly
Journal:  Postgrad Med J       Date:  1982-11       Impact factor: 2.401

Review 3.  Childhood acute lymphoblastic leukaemia: a review.

Authors:  M L Willoughby
Journal:  J R Soc Med       Date:  1982-06       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.